JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krieger-Brauer, H. I.
Right arrow Articles by Kather, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krieger-Brauer, H. I.
Right arrow Articles by Kather, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 40, 28308-28313, October 1, 1999


An Antibody Directed against Residues 100-119 within the alpha -Helical Domain of Galpha s Defines a Novel Contact Site for beta -Adrenergic Receptors*

Heidemarie I. Krieger-Brauer, Pankaj K. Medda, Ulrike Hebling, and Horst Kather

From the Klinisches Institut für Herzinfarktforschung an der Medizinischen Universitätsklinik Heidelberg, Bergheimerstraße 58, D-69115 Heidelberg, Germany

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

A polyclonal antiserum that recognizes residues 100-119 within the alpha -helical domain of Galpha s (K-20) caused a dissociation of Gs into its component subunits and activated a cholera toxin-sensitive high affinity GTPase. Consistently, the antibody mimicked the stimulatory effects of the beta -adrenergic agonist, isoproterenol, on adenylyl cyclase, which is mediated by Galpha s, and its inhibitory action on NADPH-dependent H2O2 generation, a Gbeta gamma -mediated response. A peptide corresponding to the target sequence of K-20 not only neutralized the receptor-mimetic effects of the antibody but inhibited the whole spectrum of isoproterenol action as well, including its antagonistic effects on adenylyl cyclase and NADPH-dependent H2O2 generation. By contrast, COOH-terminal anti-Galpha s selectively inhibited the stimulatory effect of isoproterenol on cAMP formation without affecting its inhibitory effect on NADPH-dependent H2O2 generation. The data are consistent with the concept that beta -adrenergic receptors interact with multiple sites on Galpha s each playing a distinct role, and strongly suggest that antibody K-20 defines a novel contact site for beta -adrenergic receptors that localizes to the alpha -helical domain and is essential for eliciting the complete spectrum of beta -adrenergic responses.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Heterotrimeric G proteins composed of alpha - and beta gamma -subunits transduce signals from cell surface receptors to downstream effectors and regulate intracellular membrane transport events (1-6). Interaction of ligand-occupied receptors with heterotrimeric G proteins triggers the exchange of GTP for GDP on the alpha -subunit, leading to a sequential release of Galpha -GTP and the stable beta gamma -complex from the receptor. The released G protein subunits are then able to interact with distinct effector enzymes and ion channels. G protein activation is terminated by hydrolysis of GTP by the intrinsic GTPase activity of the alpha -subunit, leading to reassociation of Galpha and Gbeta gamma . The cycle is then complete, and the heterotrimeric G protein is able to be activated again.

The structural determinations for several members of the family of heterotrimeric G proteins have shown that their alpha -subunits are composed of two domains (1-6). The core domain contains regions with sequence similarity to other GTPases and has a structure very similar to Ras and elongation factor Tu (1-6). The alpha -helical domain is unique to alpha -subunits of heterotrimeric proteins and not present in other GTPases. It is therefore tempting to assume that the latter domain may be important for specific functions of heterotrimeric G proteins that are not shared by other members of the GTPase superfamily, such as coupling to heptahelical receptors. Surprisingly, current modeling suggests that receptor-G protein coupling is exclusively by the core domain of Galpha and segments of the beta - and gamma -subunits, however (1-6). The function of the alpha -helical domain is still under investigation. Evidence has been presented to suggest that it may influence the spontaneous rate of GDP release (7), and it has been proposed that it may function as a GTPase-activating protein (8), or may be involved in effector regulation (9).

A screening of different Galpha s antibodies for their applicability in studying insulin receptor-NADPH oxidase coupling revealed that one of the commercially available antibodies (K-20), which recognizes residues 100-119 within the alpha -helical domain of Galpha s, mimicked the effects of inhibitory ligands, such as the beta -adrenergic agonist isoproterenol, on NADPH-dependent H2O2 generation that are transduced by Gs. We therefore explored whether the epitope recognized by K-20 may define a new contact site for activated beta -adrenergic receptors or be involved in an alternative route of Gs activation that may be utilized for a receptor-independent activation of Gs by intracellular pseudoreceptors or accessory proteins, for example (10-15).

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials

The characteristics and sources of antibodies and Gs-derived peptides used in the current experiments are listed in Table I. Forskolin, 7beta -deacetyl-7beta -(gamma -(morpholino)butyryl)hydrochloride, was from Research Biochemicals International and cholera toxin (A-subunit) from Calbiochem.

Methods

Subjects, Preparation of Fat Cells, and Fat Cell Ghosts-- Experimental details have been described in detail elsewhere (16). Briefly, adipose tissue was from nondiabetic subjects undergoing elective abdominal or cosmetic breast surgery. The specimens were cut into small pieces, and fat cells were isolated in a HEPES-buffered Krebs-Henseleit solution, pH 7.4, containing 20 mM HEPES, 10 mM NaHCO3, 5 mM glucose, 20 g/liter albumin, and 1 mg/ml collagenase (CLS, Worthington). After 30 min, fat cells were washed and resuspended in 10 volumes of an ice-cold lysing medium containing 20 mM MES,1 pH 6.0, 2 mM MgCl2, 1 mM CaCl2, 5 mM KCl, and 100 mg/liter soybean trypsin inhibitor. Cell lysis was completed by mechanical shaking, and fat cell ghosts were collected by low speed centrifugation (1,000 × g, 4 °C, 20 min).

Receptor-mediated Modulation of NADPH-dependent H2O2 Generation-- A two-step procedure was used, as reported elsewhere (16). Plasma membranes from adipocytes were first exposed to hormones and were then assayed for NADPH oxidase activity. The activation step was carried out in 30 mM MOPS, pH 7.5, containing 120 mM NaCl, 1.4 mM CaCl2, 2.5 mM MgCl2, 10 mM NaHCO3, and 0.1% human albumin. Membranes were first incubated with 5 nM insulin in absence or presence of 5 µM isoproterenol for 5 min to allow receptor occupation. Thereafter, 50 µM GTPgamma S was added. After 20 min, ghosts were collected by centrifugation, washed, and then resuspended in 30 mM MES, pH 5.8, containing 120 mM NaCl, 4 mM MgCl2, 1.2 mM KH2PO4, 1 mM NaN3, 250 µM NADPH, and 10 µM FAD for determination of NADPH-dependent H2O2 generation.

To assess the effects of G protein antibodies and peptides corresponding their target sequences on NADPH-dependent H2O2 generation, membranes were exposed to both types of agents at 4 °C for 45 min, as indicated in the legends to figures, and were then subjected to the two-step procedure described above.

Determination of Adenylyl Cyclase Activity-- Adenylyl cyclase activity of human fat cell plasma membranes was determined in 30 mM Tris-HCl, pH 7.5, containing 1 mM ATP, 2.5 mM MgCl2, 0.5 mM EDTA, 0.5 mM 3-isobutyl-1-methylxanthine, 10 µM GTP, 10 mM creatine phosphate, 0.1 mg of creatine kinase, and 0.1% bovine serum albumin in a final volume of 100 µl. Reactions were initiated by addition of 5-8 µg of membrane protein and were continued for 15 min at 37 °C in the absence or presence of isoproterenol, as indicated. Reactions were terminated by 100 µl of ice-cold perchloric acid (5%). cAMP was determined by radioimmunoassay (Amersham Pharmacia Biotech) after neutralization. To assess the effect of Galpha s-derived peptides and antibody K-20 on adenylyl cyclase activity, membranes were pretreated with the K-20 antibody or peptides, as described above.

Cholera Toxin Treatment-- For cholera toxin (CTX) labeling, membranes (500 µg) were incubated for 45 min at 37 °C in 1 ml of 30 mM MOPS, pH 7.5, containing 2.5 mM MgCl2, 1.4 mM CaCl2, 120 mM NaCl, 10 mM thymidine, 10 mM arginine, 10 µM GTP, 10 µM NAD, and 100 µg of cholera toxin A subunit. Membranes were washed and then subjected to GTPase assay.

GTPase Activity-- GTP hydrolysis was determined essentially as described by Jakobs and Aktories (20). Untreated or CTX-treated membranes were preincubated (20 min, 4 °C) in 20 mM Tris-HCl, pH 7.6, containing 2.5 mM MgCl2, 0.5 mM EDTA, and 100 µM N-ethylmaleimide (NEM) to inactivate Gi. After washing, NEM-treated membranes were exposed to antibody K-20 or the peptide corresponding to its target sequence for 40 min at 0 °C, as indicated. For determination of GTPase activity membranes (5-10 µg of protein) were incubated in 0.1 ml Tris-HCl (20 mM, pH 7.6) containing 0.2 µM GTP, 0.5 mM ATP, 0.5 mM AMP(PNP), 2.5 mM Mg Cl2, 1 mM EDTA, 1 mM dithiothreitol, 5 mM creatine phosphate, 0.025 mg of creatine kinase, and [gamma -32P]GTP (0.1-0.2 µmol) at 37 °C for 10 min. Reactions were terminated by addition of 25% (w/v) activated charcoal. Release of 32Pi was determined by counting aliquots of the supernatants for radioactivity.

Low affinity GTPase activity was determined by measuring the rate of GTP hydrolysis at 50 mM GTP. Less than 16% of total GTP hydrolysis was due to low affinity GTPases under the conditions used.

K-20-induced Dissociation of Gs-- In contrast to other G proteins, Galpha s does not dissociate in the presence of GTPgamma S alone under the conditions used in the present experiments (17, 18). Plasma membranes were therefore suspended in activation buffer containing 50 µM GTPgamma S, as described above, and incubated in the absence or presence of various concentrations K-20 for 25 min at ambient temperature, as indicated in the legend to Fig. 1.

Immunoprecipitation-- After treatment with K-20, membranes were pelleted and solubilized in 1% Triton X-100 for 30 min at 0 °C. Gs was immunoprecipitated by COOH-terminal anti-Galpha s (RM/1), which does not discriminate between heterotrimeric and monomeric Galpha s (17, 18). Immunoprecipitations were carried out in 10 mM Tris-HCl, ph 7.4, containing 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.5% Nonidet P-40, proteinase inhibitors (0.4 mM phenylmethylsulfonyl fluoride, 2 µM leupeptin, 2 µM pepstatin, 1 unit/ml aprotinin), and antibody RM/1 at a dilution of 1:80 and 50 µM GTPgamma S. The samples (30 µg of membrane protein/100 µl of precipitation buffer) were incubated overnight at 4 °C. The immune complexes were captured with protein A-agarose beads (Amersham Pharmacia Biotech) and washed three times with 1 ml of washing buffer (10 mM Tris, pH 7.4, containing 1% Triton X-100, 150 mM NaCl, 1 mM EGTA, 1 mM EDTA, and the protease inhibitors). The beads were boiled in SDS-sample buffer.

Proteins were separated by SDS-polyacrylamide gel electrophoresis and transferred to Hybond polyvinylidene difluoride membranes. Western blotting was performed using anti-Galpha s (RM/1) and anti-Gbeta (SW/1 from NEN Life Science Products) antibodies. Bands were visualized by chemiluminescence using the ECL kit from Amersham Pharmacia Biotech and were quantified by densitometric analysis. The amount of Gbeta was normalized to the amount of Galpha s immunoprecipitated for each condition.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Antibody K-20 selectively precipitated Galpha s; neither Galpha i nor Galpha o was detectable after precipitation of solubilized membrane proteins by K-20 (data not shown).

Fig. 1 shows that antibody K-20 was not only capable of specifically recognizing Galpha s but also promoted dissociation of Gs into its component subunits in the presence of GTPgamma S. Membranes were pretreated with different K-20 concentrations and monitored for dissociation of Gs by a immunoblot technique utilizing antibody RM/1, which does not discriminate between heterotrimeric and monomeric Galpha s (17, 18). Fig. 1 demonstrates that the amount of Gbeta recovered in RM/1 immunoprecipitates was selectively reduced in membranes that had been pretreated with K-20 in the presence of 50 µM GTPgamma S. In the absence of GTPgamma S, the antibody had no influence on the subunit composition of Gs, indicating that K-20 caused a guanine nucleotide triphosphate-dependent dissociation of Gs, which is characteristic for a receptor-mediated activation (1-5).


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 1.   An antibody directed against residues 100-119 within the alpha -helical domain of Galpha s (K-20) causes dissociation of Gs into its component subunits. Plasma membranes were incubated in the presence of 50 µM GTPgamma S either alone, or with antibody K-20 for 25 min. Thereafter, Galpha s was immunoprecipitated using the polyclonal antibody RM/1, as described under "Methods." The immunoprecipitates were resolved by SDS-polyacrylamide gel electrophoresis and immunoblotted for Galpha s and Gbeta using the antibodies RM/1 and SW/1, respectively. The amounts of Galpha s and the coimmunoprecipitated Gbeta were determined by densitometric analysis. The amount of Gbeta was normalized to the amount of Galpha s immunoprecipitated for each condition. Results are the means ± S.E. of four independent experiments.

The latter observation suggested that K-20 may bind to and activate Gs in a manner similar to activated heptahelical receptors. To corroborate this latter hypothesis, untreated and cholera toxin-treated membranes were incubated with increasing concentrations of K-20 and assayed for high affinity GTPase activity in the presence of NEM, which inactivates Gi (20). The antibody caused a concentration-dependent increase in GTP hydrolysis, which was abolished after treatment with cholera toxin (Fig. 2A). At a maximal concentration (1:1,000), the antibody increased GTPase activity by approximately one-third, which is similar to the extent of activation seen in the presence of a maximal concentration of the beta -adrenergic agonist isoproterenol (Fig. 2B).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2.   Antibody K-20 stimulates a cholera toxin-sensitive high affinity GTPase in human fat cell plasma membranes. A, untreated (black-square) and CTX-treated (black-triangle) plasma membranes were exposed to various concentrations of K-20 for 1 h at 4 °C, and then assayed for GTPase activity, as described under "Methods." B, effect of increasing concentrations of isoproterenol on GTPase activities in untreated (black-square) and CTX-treated (black-triangle) membranes. Basal GTPase activity of untreated controls was 9.9 ± 1.1 pmol × mg-1 × min-1. Values are means ± S.D. of seven separate experiments carried out in triplicate. *, p < 0.01 (paired t test).

Consistent with its stimulatory effects on GTP hydrolysis by Gs, K-20 activated adenylyl cyclase activity in human fat cell plasma membranes over the same range of concentrations that were effective in stimulating GTPase activity (Fig. 3A); the maximal effect of the antibody was similar to that seen in the presence of isoproterenol (16). Activation of adenylyl cyclase was not the sole isoproterenol-like effect of K-20 (Fig. 3B). The antibody mimicked the inhibitory effect of the beta -adrenergic agonist on NADPH-dependent H2O2 generation as well, which is mediated by beta gamma -subunits (16). At maximal concentrations, both isoproterenol and K-20 inhibited the stimulatory effect of insulin on NADPH-dependent H2O2 generation completely, and their effects could be reversed by Gbeta -antibodies or agents that specifically bind Gbeta gamma 2. Thus, K-20 mimicked the action of activated beta -adrenergic receptors in every aspect studied, suggesting that the epitope recognized by K-20 may either define a new contact site for beta -adrenergic receptors on the alpha -helical domain of Gs or be involved in an alternative route of Gs activation that may be utilized for a receptor-independent activation of Gs.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 3.   K-20 mimics the effects of activated beta -adrenergic receptors on adenylyl cyclase and NADPH oxidase activities. Plasma membranes were pretreated with increasing dilutions of K-20 for 45 min at 22 °C, and then assayed for adenylyl cyclase (A) and NADPH oxidase (B) activities, as described under "Methods." Values are means ± S.D. of six (adenylyl cyclase) or three (NADPH oxidase) separate experiments carried out in duplicate.

The stimulatory effect of K-20 on GTP hydrolysis could be neutralized by a peptide corresponding to its target sequence, as expected (Fig. 4A). Surprisingly, the peptide not only neutralized the effect of the antibody on GTPase activity but inhibited isoproterenol action on GTP hydrolysis as well (Fig. 4B). At a concentration of 2.5 µM, the peptide suppressed the stimulatory effect of isoproterenol over the whole range of concentrations tested, suggesting that the epitope recognized by K-20 may in fact be essential for interaction of activated beta -adrenergic receptors with Gs (Fig. 4B).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 4.   Reversal of the stimulatory effect of isoproterenol on GTP hydrolysis by a peptide corresponding to the target sequence of K-20 (residues 100-119 of Galpha s). A, neutralization of K-20 action by peptide 100-119. K-20 (dilution 1:10,000) was preincubated in the absence or presence of 2.5 µM peptide 100-119 for 1 h at 4 °C, and then assayed for its effect on high affinity GTPase activity, as described. B, reversal of the stimulatory effect of isoproterenol on high affinity GTPase activity. Membranes (5 µg of protein) were preincubated in the absence (black-square) or presence (black-triangle) of 2.5 µM peptide 100-119 for 1 h at 4 °C, and then assayed for isoproterenol-stimulated GTPase activity, as described. Values are means ± S.D. of three separate experiments for each condition.

Fig. 5 compares the effects of peptide 100-119 and of a COOH-terminal decapeptide derived from Galpha s (Table I) on isoproterenol-stimulated rates of cAMP formation and its inhibitory effect on NADPH-dependent H2O2 generation. At the concentrations used, both peptides decreased isoproterenol induced cAMP production to basal levels (Fig. 5A). The inhibitory effect of isoproterenol on NADPH-dependent H2O2 generation was also reversed by peptide 100-119 (Fig. 5B). Surprisingly, the COOH-terminal decapeptide was only effective in inhibiting cAMP formation, a Galpha s-mediated response, but failed to influence the inhibitory effect of isoproterenol on NADPH-dependent H2O2 generation, which is mediated by beta gamma -subunits (Fig. 5B). The effect of peptide 100-119 was specific, inasmuch as this fragment had no effect on forskolin-stimulated rates of cAMP production (Fig. 6).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 5.   Reversal of the antagonistic effects of isoproterenol on adenylyl cyclase and NADPH oxidase activities by peptide 100-119: comparison with the effects of a COOH-terminal peptide corresponding to residues 385-394 of Galpha s. Plasma membranes were preincubated for 45 min at 4 °C in the absence (black-square) or presence of 7.5 µM peptide corresponding to residues 385-394 (triangle ) or of 2.5 µM peptide corresponding to residues 100-119 (black-triangle). A, suppression of the stimulatory effects of isoproterenol on cAMP production by both peptides. Membranes were assayed for adenylyl cyclase activity in the presence of increasing concentrations of isoproterenol, as described under "Methods." Addition of vehicle had no effect on isoproterenol stimulated adenylyl cyclase activity. B, selective reversal of the isoproterenol-induced inhibition of NADPH-dependent H2O2 generation by peptide 100-119. Membranes were incubated with 5 nM insulin and 50 µM GTPgamma S in absence or presence of 5 µM isoproterenol, and then assayed for NADPH oxidase activity. Addition of vehicle had no effect on isoproterenol induced inhibition of H2O2 generation. Values are means ± S.D. of four separate experiments for each condition.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Antibodies and peptide sequences


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 6.   Lacking effect of peptide 100-119 on forskolin-induced cAMP formation. Membranes were preincubated in the absence or presence of 2.5 µM peptide 100-119 and were stimulated by forskolin for 10 min and then assayed for adenylyl cyclase activity as described under "Methods." Values are means ± S.D. of three separate experiments carried out in duplicate.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

This report demonstrates that polyclonal antibodies directed against a segment of the alpha -helical domain encompassing residues 100-119 of Galpha s caused a dissociation of Gs into its component subunits, stimulated a cholera toxin-sensitive high affinity GTPase, and were as efficient in stimulating adenylate cyclase activity as the beta -adrenergic agonist isoproterenol, suggesting that this antibody binds to and stimulates Gs in manner similar to that of ligand-occupied receptors. Consistently, the antibody not only stimulated adenylate cyclase but mimicked the inhibitory action of isoproterenol on NADPH-dependent H2O2 generation as well, which is mediated by Gbeta gamma , indicating that activation of a single G protein, Gs, can provide enough Gbeta gamma for eliciting a Gbeta gamma -mediated response, which has been questioned (21). With one possible exception (22), K-20 is the first example of an antibody exhibiting receptor-mimetic effects, a property that should be extremely useful in elucidating the role of Gs in processes where receptors have not yet been identified, such as membrane traffic (11, 23) or complex cellular responses, including cell differentiation (24).

The antigenic site recognized by antibody K-20 encompasses the distal end of helix A and the beginning of the following loop, a region of general sequence diversity among Galpha -subunits that is freely accessible and seems to be poorly ordered in crystals of Galpha s-GTPgamma S (25). Interestingly, in Galpha i2, an adjacent region, e.g. the helix B-helix C segment, undergoes substantial structural changes upon GTP hydrolysis resulting in an opening of the nucleotide binding pocket (26). However, current modeling suggests that the antigenic site recognized by K-20 may be too distant from the plasma membrane (>35 Å) to be involved in direct physical contact with activated beta -adrenergic receptors (5, 6), raising the interesting possibility that helix A and the beginning of the following loop may be utilized for a receptor-independent activation of Gs. Indeed, it is well established that the activity of G proteins may be directly modulated by a diverse group of proteins, including terminal complement complexes (13), presenilin (15), neuromodulin (11), tubulin (27), caveolins (28, 29), not yet identified proteins (12), or amphiphilic small molecular weight compounds, such as mastoporans (10), carbolins (30), and taste substances (14). Surprisingly, the peptide corresponding to the antigenic site of K-20 (residues 100-119) not only neutralized the action of the antibody but impaired beta -adrenergic receptor signaling via both component subunits of Gs as well, which resulted in inhibition of all effects of isoproterenol tested, including its antagonistic effects on adenylyl cyclase and NADPH-dependent H2O2 generation. Peptides that are effective in blocking receptor-G protein interaction are believed to mimic interfacial contact sites between the proteins. Indeed, this latter type of peptide competition now serves as a standard approach to identifying protein interaction pairs and their recognition sequences (31). Although provocative, it therefore appears safe to conclude that peptide 100-119 competed with Galpha s for activated beta -adrenergic receptors, implying that the epitope recognized by antibody K-20 within the alpha -helical domain is directly accessible for this class of heptahelical receptors. Consistently, the peptide did not influence the stimulatory effect of forskolin which activates adenylyl cyclase directly.

As pointed out above, the conclusion that peptide 100-119 competed with Galpha s for activated beta -adrenergic receptors implies that current ideas regarding the orientation of heterotrimeric Gs relative to the membrane and/or receptors may require careful reevaluation (1, 2, 4, 6). Much current thinking is based on the idea of freely mobile receptors, G proteins, and effectors (1-6). Based on this concept, current models predict that the heterotrimer face that interacts with receptors comprises the NH2 and COOH termini of Galpha , exposed residues on helix alpha 5 and strand beta 6, as well as the COOH terminus of the gamma -subunit and the sixth or seventh WD repeat of Gbeta . The alpha -helical domain is thought to form the cytosolic pole of Galpha (1, 2, 4-6). However, heterotrimeric G proteins are enriched in highly organized vesicular invaginations of the plasma membrane termed caveolae, which may represent sites of assembly of a signal transducing complex that could include receptors, G proteins, effectors, and even intracellular targets of the second messengers generated (28, 29). It has been reported that G proteins bind to chief structural proteins of these organelles, the caveolins, via a sequence that lies between the switch-I and switch-II regions of the alpha -subunit (28, 29). An incorporation of this latter site into structural models of the receptor/G protein complex changes the predicted orientation of the G protein in a way that brings the alpha -helical domain in close proximity to the membrane, which is consistent with the present data predicting a direct contact of activated beta -adrenergic receptors with the distal end of helix A and the beginning of the following loop.

Overall, it thus appears that antibody K-20 defines an as yet unrecognized contact site for beta -adrenergic receptors on Galpha s that localizes to the alpha -helical domain. This latter segment is the first example of a receptor binding region outside the core GTPase domain of Galpha and is essential for eliciting the responses transmitted by both Galpha s and Gbeta gamma s.

As yet, the most precisely defined site of receptor contact involves the extreme carboxyl terminus, which is thought to be of fundamental importance for receptor recognition and G protein activation (1-6, 32-35). Indeed, COOH-terminal anti-Galpha s and the peptide corresponding to its target sequence were as efficacious as peptide 100-119 in blocking the isoproterenol-induced stimulation of adenylyl cyclase, indicating that the extreme carboxyl terminus is in fact necessary for beta -adrenergic receptor signaling via Galpha s. However, in contrast to peptide 100-119, COOH-terminal anti-Galpha s failed to prevent the isoproterenol-induced suppression of NADPH-dependent H2O2 generation, a Gbeta gamma s-mediated response. Thus, a contact of activated beta -adrenergic receptors with the extreme carboxyl terminus of Galpha s appears to be required solely for receptor signaling via Galpha s but is apparently not critical for receptor recognition and dissociation of the Gs heterotrimer. The latter finding is difficult to reconcile with current models of G protein activation but is consistent with the observations of others, indicating that COOH-terminal Galpha s antibodies act as reliable and specific inhibitors of receptor signaling via Galpha -subunits only. By contrast, their effects on Gbeta gamma -mediated responses are variable and may depend on the G protein, receptors, or cell type studied. Thus, antibodies directed against the COOH termini of Galpha q and Galpha 13 have been shown to block signaling by m3 muscarinic and AT1A angiotensin II receptors via both types of component subunits of Gq and G13, while anti- Galpha i1, and anti-Galpha o, or anti-Galpha s had no effect on Gbeta gamma -mediated responses elicited by sstr 3-somatostatin receptor stimulation or during transcytosis, respectively (23, 36-38).

Together with the essential role of the epitope recognized by antibody K-20, the observation that COOH-terminal anti-Galpha s selectively impaired beta -adrenergic receptor signaling via Galpha s without affecting the Gbeta gamma s-mediated response is consistent with the concept that beta -adrenergic receptors interact with multiple sites on Galpha s, each playing a distinct role, as has also been proposed by others (39). More importantly, this latter finding implies that the activation and/or release of Gbeta gamma s by ligand-occupied beta -adrenergic receptors may not require the simultaneous activation of Galpha s, which is in marked contrast to current concepts of G protein regulation. A subunit-specific activation of a G protein has in fact been described for the insulin-like growth factor II receptor, which may selectively turn on Galpha iota 2-mediated pathways (40). However, this latter type of selectivity is achieved through sequestration of free beta gamma -subunits by the activated receptors, which is not comparable with the mechanism outlined above. Whether receptors exist that selectively activate Galpha without affecting the function of Gbeta gamma or vice versa remains to be established.

In conclusion, the current findings show that a commercially available polyclonal antiserum directed against residues 100-119 within the alpha -helical domain of Galpha s (K-20) acts as a beta -adrenergic receptor-mimetic agent, and defines a novel contact site for activated beta -adrenergic receptors that localizes to the alpha -helical domain. In contrast to the COOH terminus of Galpha s, which seems to be critical for beta -adrenergic receptor signaling via Galpha s only, the epitope recognized by antibody K-20 appears to be essential for eliciting the complete spectrum of beta -adrenergic responses mediated by both Galpha s as well as Gbeta gamma s.

    ACKNOWLEDGEMENT

We are indebted to Brigitte Sattel for expert technical assistance.

    FOOTNOTES

* This work was supported by a grant from the Deutsche Forschungsgemeinschaft, Bonn-Bad Godesberg, Germany.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

2 H. I. Krieger-Brauer, B. Sattel, P. Medda, and H. Kather, submitted for publication.

    ABBREVIATIONS

The abbreviations used are: MES, 2-(N-morpholino)ethanesulfonic acid; GTPgamma S, guanosine-5'-O-(3-thiotriphosphate); MOPS, 3-(N-morpholino)propanesulfonic acid; AMP(PNP), adenylyl imidodiphosphate; PBS, phosphate-buffered saline; CTX, cholera toxin; NEM, N-ethylmaleimide.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Neer, E. J. (1995) Cell 80, 249-257[CrossRef][Medline] [Order article via Infotrieve]
2. Hamm, H. E., and Gilchrist, A. (1996) Curr. Opin. Cell Biol. 8, 189-196[CrossRef][Medline] [Order article via Infotrieve]
3. Rodbell, M. (1997) Adv. Enzyme Regal. 37, 427-435[CrossRef][Medline] [Order article via Infotrieve]
4. Neubig, R. R. (1994) FASEB J. 8, 939-946[Abstract]
5. Bohm, A., Gaudet, R., and Sigler, P. B. (1997) Curr. Opin. Biotechnol. 8, 480-487[CrossRef][Medline] [Order article via Infotrieve]
6. Iiri, T., Farfel, Z., and Bourne, H. R. (1998) Nature 394, 35-38[CrossRef][Medline] [Order article via Infotrieve]
7. Osawa, S., Dhanasekaran, N., Woon, C. W., and Johnson, G. L. (1990) Cell 63, 697-708[CrossRef][Medline] [Order article via Infotrieve]
8. Markby, D. W., Onrust, R., and Bourne, H. R. (1993) Science 262, 1895-1901[Abstract/Free Full Text]
9. Lin, W., and Northup, J. K. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 12878-12883[Abstract/Free Full Text]
10. Higashijima, T., Uzu, S., Nakajima, T., and Ross, F. M. (1988) J. Biol. Chem. 263, 6491-6494[Abstract/Free Full Text]
11. Vitale, N., Deloulme, J. C., Thierse, D., Aunis, D., and Bader, M. F. (1994) J. Biol. Chem. 269, 30293-30298[Abstract/Free Full Text]
12. Sato, M., Ribas, C., Hildebrandt, J. D., and Lanier, S. M. (1996) J. Biol. Chem. 271, 30052-30060[Abstract/Free Full Text]
13. Niculescu, F., Rus, H., and Shin, M. L. (1994) J. Biol. Chem. 269, 4417-4423[Abstract/Free Full Text]
14. Naim, M., Seifert, R., Nürnberg, B., Grünbaum, L., and Schultz, G. (1994) Biochem. J. 297, 451-454
15. Smine, A., Xu, X., Nishiyama, K., Katada, T., Gambetti, P., Yadaw, S. P., Wu, X., Shi, Y.-C., Yasuhara, S., Homburger, V., and Okamoto, T. (1998) J. Biol. Chem. 273, 16281-16288[Abstract/Free Full Text]
16. Krieger-Brauer, H. I., Medda, P. K., and Kather, H. (1997) J. Biol. Chem. 272, 10135-10143[Abstract/Free Full Text]
17. Togoshige, M., Okuga, S., and Rebois, R. V. (1994) Biochemistry 33, 4865-4871[CrossRef][Medline] [Order article via Infotrieve]
18. Togoshige, M., Basi, N. S., and Rebois, R. V. (1996) J. Biol. Chem. 271, 8791-8795[Abstract/Free Full Text]
19. Cassel, D., and Selinger, Z. (1976) Biochim. Biophys. Acta 452, 538-551[Medline] [Order article via Infotrieve]
20. Jakobs, K. H., and Aktories, K. (1988) Biochem. J. 249, 639-643[Medline] [Order article via Infotrieve]
21. Taussig, R., Tang, W. J., Hepler, J. R., and Gilmann, A. G. (1994) J. Biol. Chem. 269, 6093-6100[Abstract/Free Full Text]
22. Yilla, M., Oleinick, J., and Ploegh, H. L. (1996) FEBS Lett. 387, 16-22[CrossRef][Medline] [Order article via Infotrieve]
23. Bomsel, M., and Mostov, K. E. (1993) J. Biol. Chem. 268, 25824-25835[Abstract/Free Full Text]
24. Wang, H. Y., Watkins, D. C., and Malbon, C. C. (1992) Nature 358, 334-337[CrossRef][Medline] [Order article via Infotrieve]
25. Sunahara, R. K., Tesmer, J. J. G., Gilman, A. G., and Sprang, S. R. (1997) Science 278, 1943-1947[Abstract/Free Full Text]
26. Mixon, M. B., Lee, E., Coleman, D. E., Berghuis, A. M., Gilman, A. G., and Sprang, S. R. (1995) Science 270, 954-960[Abstract/Free Full Text]
27. Roychowdhury, S., and Rasenick, M. M. (1994) Biochemistry 33, 9800-9805[CrossRef][Medline] [Order article via Infotrieve]
28. Li, S., Okamoto, T., Chun, M., Sargiacomo, M., Casanova, J. F., Hansen, S. H., Nishimoto, J., and Lisanti, M. P. (1995) J. Biol. Chem. 270, 15693-15701[Abstract/Free Full Text]
29. Couet, J., Li, S., Okamoto, T., Ikezu, T., and Lisanti, M. P. (1997) J. Biol. Chem. 272, 6525-6533[Abstract/Free Full Text]
30. Klinker, J. F., Seifert, R., Damm, H., and Rommelspacher, H. (1997) Biochem. Pharmacol. 53, 1621-1626[CrossRef][Medline] [Order article via Infotrieve]
31. Taylor, J. M., and Neubig, R. R. (1994) Cell. Signalling 6, 841-849[CrossRef][Medline] [Order article via Infotrieve]
32. Simonds, W. F., Goldschmidt, P. K., Codina, J., Unson, C. G., and Spiegel, A. M. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 7809-7813[Abstract/Free Full Text]
33. Masters, S. B., Sullivan, K. A., Miller, R. T., Beiderrman, B., Lopez, N. G., Ramachandran, J., and Bourne, H. R. (1988) Science 241, 448-451[Abstract/Free Full Text]
34. Liu, J., Conklin, B. R., Blin, N., Yun, J., and Wess, J. (1995) Proc. Natl. Acad. Sci. U. S. A. 95, 11642-11646
35. Conklin, B. R., Farfel, Z., Lustig, K. D., Julius, D., and Bourne, H. R. (1993) Nature 363, 274-276[CrossRef][Medline] [Order article via Infotrieve]
36. Stehno-Bittel, L., Krapivinsky, P., Krapivinsky, L., Perez-Terzic, C., and Clapham, D. E. (1995) J. Biol. Chem. 270, 30068-30074[Abstract/Free Full Text]
37. Macrez, N., Morel, J.-L., Kalkbrenner, K., Viard, P., Schultz, G., and Mironneau, J. (1997) J. Biol. Chem. 272, 23180-23185[Abstract/Free Full Text]
38. Murthy, K. S., Coy, D. H., and Makhlouf, G. M. (1996) J. Biol. Chem. 271, 23458-23463[Abstract/Free Full Text]
39. Skiba, N. P., and Hamm, H. E. (1996) J. Biol. Chem. 271, 413-424[Abstract/Free Full Text]
40. Ikezu, T., Okamoto, T., Giambarella, U., Yokota, T., and Nishimoto, J. (1995) J. Biol. Chem. 270, 29224-29228[Abstract/Free Full Text]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. E. Slessareva, H. Ma, K. M. Depree, L. A. Flood, H. Bae, T. M. Cabrera-Vera, H. E. Hamm, and S. G. Graber
Closely Related G-protein-coupled Receptors Use Multiple and Distinct Domains on G-protein {alpha}-Subunits for Selective Coupling
J. Biol. Chem., December 12, 2003; 278(50): 50530 - 50536.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. I. Krieger-Brauer, P. K. Medda, B. Sattel, and H. Kather
Inhibitory Effect of Isoproterenol on NADPH-dependent H2O2 Generation in Human Adipocyte Plasma Membranes Is Mediated by beta gamma -Subunits Derived from Gs
J. Biol. Chem., January 28, 2000; 275(4): 2486 - 2490.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. I. Krieger-Brauer, P. Medda, and H. Kather
Basic Fibroblast Growth Factor Utilizes Both Types of Component Subunits of Gs for Dual Signaling in Human Adipocytes. STIMULATION OF ADENYLYL CYCLASE VIA Galpha s AND INHIBITION OF NADPH OXIDASE BY Gbeta gamma s
J. Biol. Chem., November 10, 2000; 275(46): 35920 - 35925.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krieger-Brauer, H. I.
Right arrow Articles by Kather, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krieger-Brauer, H. I.